Sapropterin Dihydrochloride Powder, For Solution
NDC Package 31722-047-30
Package Information
Sapropterin Dihydrochloride powders is a medication used along with diet changes for long-term treatment of a certain inherited disorder (phenylketonuria-PKU). This formulation utilizes a powder, for solution delivery system. Marketed by Camber Pharmaceuticals, Inc., this product is identified by NDC 31722-047 and is authorized under FDA application ANDA215420.
Identification & Billing
- RxCUI: 1111018 - sapropterin dihydrochloride 100 MG Powder for Oral Solution
- RxCUI: 1653217 - sapropterin dihydrochloride 500 MG Powder for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 31722 - Camber Pharmaceuticals, Inc.
- 31722-047 - Sapropterin Dihydrochloride
- 31722-047-30 - 30 PACKET in 1 CARTON / 1 POWDER, FOR SOLUTION in 1 PACKET (31722-047-01)
- 31722-047 - Sapropterin Dihydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (31722-047). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 31722-047-30 identifies a specific commercial package of 30 packet in 1 carton / 1 powder, for solution in 1 packet (31722-047-01) of Sapropterin Dihydrochloride, a human prescription drug labeled by Camber Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This powder, for solution is formulated for oral use and contains sapropterin dihydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Camber Pharmaceuticals, Inc. on August 18, 2022. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used along with diet changes for long-term treatment of a certain inherited disorder (phenylketonuria-PKU). It helps remove a certain chemical (phenylalanine) from the body. Too much phenylalanine in the body can cause brain damage.
How is this Camber Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 31722004730. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.